Graybug Vision Completes Treatment Phase of ALTISSIMO Trial in Wet AMD with 12-Month Topline Data Expected in Second Quarter 2021
January 07, 2021 07:30 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat...
Clearside Biomedical Announces Pricing of $12 Million Registered Direct Offering
January 06, 2021 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
December 22, 2020 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Dec. 22, 2020 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today...
Novartis reports positive topline results from second Phase III trial of Beovu® in patients with diabetic macular edema
December 15, 2020 01:15 ET
|
Novartis International AG
In Phase III KESTREL study, Beovu (brolucizumab 6 mg) achieved its primary endpoint of non-inferiority to aflibercept 2 mg in change in best-corrected visual acuity (BCVA) at year one (week 52)1In a...
Ocugen Inc. Announces Plan to Postpone Annual Meeting of Stockholders
December 10, 2020 17:44 ET
|
Ocugen
MALVERN, Pa., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure...
Outlook on the Retinal Surgery Devices Global Market to 2025 - by Equipment Type, Application, End-use and Region
December 01, 2020 06:43 ET
|
Research and Markets
Dublin, Dec. 01, 2020 (GLOBE NEWSWIRE) -- The "Retinal Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
CEO Dr. Shankar Musunuri to be Featured as a Panelist at Xconomy’s Xcelerating Life Sciences Virtual Event Discussing The Promise of Cell & Gene Therapies
November 27, 2020 08:09 ET
|
Ocugen
MALVERN, Pa., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure...
Global Wave-front Aberrometer Market Report 2020-2025: Companies are Taking Initiatives, Such as Launching New Products to Expand their Presence
November 26, 2020 06:13 ET
|
Research and Markets
Dublin, Nov. 26, 2020 (GLOBE NEWSWIRE) -- The "Wave-front Aberrometer Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Myopia...
Cross Keys Capital Advises Retina Associates of Sarasota on Their Partnership with Retina Consultants of America
November 18, 2020 15:44 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Florida, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Retina Associates of Sarasota (RAS) in its partnership with Retina...
Graybug Vision to Participate in the 32nd Annual Piper Sandler Healthcare Conference
November 16, 2020 16:05 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the...